NEU 0.51% $13.72 neuren pharmaceuticals limited

Share Price, page-7535

  1. 6,137 Posts.
    lightbulb Created with Sketch. 1638
    Reggie,

    I look at it this way, the final arbiter of 'value' IS the SP. We can all do our valuations and come to the conclusion that we are 'undervalued'.

    The question is WHY?

    After all, we have been valued by the market at up to $15 a short time ago. Now for no apparent fundamentals based reason we are valued way below that and struggling to hold $10.

    What is the reason?

    I can suggest a combination of possibilities:

    1. That the rational market (if such a thing actually exists) considers that there is still reasonable risk ahead (Daybue uptake and 2591 results) and is holding back until some of that risk is ameliorated.

    2. That the market is totally asleep to the potential which is resulting in illiquidity.

    3. (And this would necessitate 2 above). There are vested interests who realise the value potential and are able to manipulate the trading to suit their accumulation or M&A intentions.

    I am betting on 3 above as being the major influence atm. I realise there are some here who scorn this scenario. Not me, as I have never trusted (and will never trust) the shenanigans that those with the wherewithal to extract financial benefit to themselves by manipulating others (to their detriment) abound in our society.

    [It's in our DNA - just follow the daily news.]
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$13.72
Change
-0.070(0.51%)
Mkt cap ! $1.732B
Open High Low Value Volume
$13.66 $13.84 $13.46 $3.333M 244.2K

Buyers (Bids)

No. Vol. Price($)
9 518 $13.71
 

Sellers (Offers)

Price($) Vol. No.
$13.73 49 3
View Market Depth
Last trade - 11.53am 05/09/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.